Display Settings:

Format

Send to:

Choose Destination
    J Neural Transm. 2010 Jul;117(7):855-9. Epub 2010 Jun 10.

    Transdermal rotigotine for the perioperative management of Parkinson's disease.

    Source

    Department of Neurology, University Bonn, Sigmund-Freud-Strasse 25, 53105, Bonn, Germany. wuellner@uni-bonn.de

    Abstract

    Continuous delivery of antiparkinsonian medication during a perioperative period is desirable to avoid 'off'-symptom complications in surgical patients with concomitant Parkinson's disease (PD). Fourteen PD patients undergoing surgery under general anesthesia were switched from oral dopaminergic medication to transdermally delivered 24-h rotigotine (median dose 12 mg/24 h) for the perioperative period. Rotigotine treatment was considered feasible by patients, their anesthesiologists and neurologists with good control of PD symptoms and easy switching and re-switching of PD medication.

    PMID:
    20535621
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2895903
    Free PMC Article

      Supplemental Content

      Icon for Springer Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk